CoChat

Orlistat in Obese Patients with Type 2 Diabetes: A Retrospective Assessment of Weight Loss and Metabolic Effects

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Almost two-thirds of the adult American population is overweight. Obesity is associated with a higher incidence of hypertension, dyslipidemia, diabetes mellitus and coronary artery disease. Orlistat, a gastrointestinal lipase inhibitor, provides an option for weight loss management in addition to diet and exercise. This study assessed the metabolic response of patients with type 2 diabetes mellitus to orlistat. Forty-one patients with type 2 diabetes who received orlistat in a private endocrinology practice were identified by a computer-assisted retrospective chart review. Orlistat's effects on weight, blood pressure, lipid parameters, hemoglobin A1C (HbA1C), and concurrent medication use were identified. Analysis of the 23 patients who remained on the drug for a minimum of 3 months revealed statistically significant reductions in patient weight, body mass index (BMI), total cholesterol, HDL cholesterol, and LDL cholesterol levels. For patients with type 2 diabetes who were able to tolerate the drug, orlistat was associated with improvement in several cardiovascular risk factors.

Overview

Integrity signals

Registry

Crossref · 10.1177/001857870403900114

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 39 references

Research works printed but not linked: 8

  1. 10.1001/archinte.1994.00420190068008 · doi:10.1001/archinte.1994.00420190068008 · Paper page
  2. 2000, Xenical [package insert].
  3. Busch R.S., 1998, Obesity Res., 5, 4S
  4. Chan J.C.N., 2001, Diabetes., 50, A108
  5. Bray G.A., 2001, Diabetes., 50, A107
  6. Deerochanawong C., 2001, Diabetes., 50, A433
  7. Shi Y.F., 2001, Diabetes., 50, A101
  8. National Heart, Lung, and Blood Institute., 2001, Third Report of the National Cholesterol Education Program Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

Cited by

See all 3

Metadata

Authors
Allie, E. C., Kane, M. P., Busch, R. S., Bakst, G., & Hamilton, R. A.
Affiliations
  • Albany College of Pharmacy and Health Sciences (US)
  • Endocrine Group, LLP, Albany, NY
Corresponding author
Allie, Edward C.
Venue
Hospital Pharmacy
Published
2004-01
Volume
39
Issue
1
Pages
37-42
ISSN
  • 0018-5787 (ISSN-L)
  • 1945-1253
OpenAlex
W2509590045
Cited by
3
References
39
Citations by year
2024: 1 · 2021: 1
FWCI
0.21
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
Hospital Pharmacy (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
orlistat, type 2 diabetes, obesity, weight loss, lipase inhibitors, glycemic control, HbA1c, lipid profile, blood pressure, cardiovascular risk factors, body mass index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Orlistat in Obese Patients with Type 2 Diabetes: A Retrospective Assessment of Weight Loss and Metabolic Effects. https://app.cochat.ai/papers/10.1177/001857870403900114
The paper
Allie, E. C., Kane, M. P., Busch, R. S., Bakst, G., & Hamilton, R. A. (2004). Orlistat in Obese Patients with Type 2 Diabetes: A Retrospective Assessment of Weight Loss and Metabolic Effects. Hospital Pharmacy. https://doi.org/10.1177/001857870403900114

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.